All Pathways
Family MedicineManagement

Chronic Pain Management (CDC 2022 Guidelines)

Chronic Pain Management (CDC 2022 Guidelines): Chronic Pain Assessment → Comprehensive Pain Evaluation → Pain Type Classification → Non-Pharmacologic Fi...

Interactive Decision Tree

Mini Map

Algorithm Steps

  1. Start

    Chronic Pain Assessment

    Pain lasting >3 months or beyond expected healing

    1. Action

      Comprehensive Pain Evaluation

      Multimodal assessment

      • Pain history: location, intensity (0-10), quality, timing
      • Functional impact: work, ADLs, sleep, mood
      • Prior treatments and response
      • Screen for depression, anxiety (common comorbidities)
      • Assess opioid risk (ORT, SOAPP-R)
      1. Decision

        Pain Type Classification

        Guide treatment selection

        • Nociceptive: Mechanical/inflammatory (OA, low back)
        • Neuropathic: Burning, shooting (diabetic, post-herpetic)
        • Nociplastic: Central sensitization (fibromyalgia)
        • Mixed: Often has components of multiple types
        1. Action

          Non-Pharmacologic First

          Foundation of chronic pain treatment

          • Physical therapy / exercise
          • Cognitive behavioral therapy for pain
          • Mindfulness-based stress reduction
          • Acupuncture (moderate evidence)
          • Massage, heat, cold therapy
          • Weight loss if applicable
          1. Action

            Ongoing Monitoring

            Required for all chronic pain management

            • Reassess pain and function regularly
            • Check PDMP before each opioid prescription
            • Urine drug screen periodically
            • Assess for opioid use disorder (DSM-5)
            • Document risk-benefit at each visit
            1. Decision

              Functional Improvement?

              Goals met with acceptable side effects

              1. Outcome

                Continue Current Therapy

                Maintain at lowest effective dose

              2. Action

                Modify Approach

                If not improving or adverse effects

                • Add non-pharmacologic modalities
                • Rotate medications
                • Consider specialty referral (pain clinic)
                • If on opioids: slow taper if not beneficial
                • Address psychosocial factors
            2. Warning

              OUD Concern

              Signs of opioid use disorder

              • Craving, loss of control, continued use despite harm
              • Offer evidence-based treatment: buprenorphine, naltrexone
              • Refer to addiction medicine if complex
              • Do not abruptly discontinue opioids
              • Harm reduction approach
        2. Action

          Non-Opioid Pharmacotherapy

          First-line medications

          • NSAIDs/acetaminophen for nociceptive pain
          • Duloxetine/venlafaxine for neuropathic/nociplastic
          • Gabapentin/pregabalin for neuropathic
          • TCAs (amitriptyline) low-dose for neuropathic
          • Topical lidocaine, capsaicin
          1. Decision

            Consider Opioids?

            Only if benefits outweigh risks

            • Non-opioid options inadequate or contraindicated
            • Functional goals clear
            • No active substance use disorder
            • Benefits expected to outweigh risks
            1. Warning

              Opioid Initiation (If Indicated)

              CDC 2022 guidance

              • Start lowest effective dose (≤50 MME/day)
              • Immediate-release before extended-release
              • Avoid ≥90 MME/day without careful reassessment
              • Co-prescribe naloxone if ≥50 MME or risk factors
              • Written treatment agreement recommended

Guideline Source

CDC Clinical Practice Guideline for Prescribing Opioids for Pain 2022

Clinical Safety Information

Clinical Decision Support — Not a Substitute for Clinical Judgment

Individual patient factors may require deviation from these recommendations.

Known Limitations

  • Does not address cancer pain or palliative care
  • Opioid tapering protocols simplified
  • Interventional procedures not detailed
  • Complex regional pain syndrome not specifically addressed
  • Substance use disorder treatment abbreviated

Applicable Regions

USAUUKEU

AU: TGA opioid regulatory framework applies

UK: NICE chronic pain pathway differs

US: CDC 2022 opioid prescribing guidelines

Version 1Next review: 2027-01-01

Frequently Asked Questions

What is the Chronic Pain Management (CDC 2022 Guidelines)?

The Chronic Pain Management (CDC 2022 Guidelines) is a management clinical algorithm for Family Medicine. It provides a structured decision tree to guide clinical decision-making, based on CDC Clinical Practice Guideline for Prescribing Opioids for Pain 2022.

What guideline is the Chronic Pain Management (CDC 2022 Guidelines) based on?

This algorithm is based on CDC Clinical Practice Guideline for Prescribing Opioids for Pain 2022 (DOI: 10.15585/mmwr.rr7103a1).

What are the limitations of the Chronic Pain Management (CDC 2022 Guidelines)?

Known limitations include: Does not address cancer pain or palliative care; Opioid tapering protocols simplified; Interventional procedures not detailed; Complex regional pain syndrome not specifically addressed; Substance use disorder treatment abbreviated. Individual patient factors may require deviation from these recommendations.

Get AI-Powered Analysis Alongside This Algorithm

In AttendMe.ai, the Chronic Pain Management (CDC 2022 Guidelines) appears automatically when your clinical question matches — alongside evidence from 3M+ peer-reviewed articles.

Try AttendMe Free